Cargando...
Could valproic acid be an effective anticancer agent? The evidence so far
Valproic acid is an inhibitor of class I histone deacetylases. Epigenetic therapies in cancer have been focus of a keen interest and HDAC inhibitors in particular have been approved for certain types of hematologic malignancies. Valproic acid is an attractive candidate for cancer therapy due to its...
Gardado en:
| Publicado en: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4579528/ https://ncbi.nlm.nih.gov/pubmed/25017212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2014.940329 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|